person

Maria E.

Country
Sweden
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
15
Sites with multiple studies

Has run more than one trial at 15 of 152 partner sites.

Specializations

Advanced Breast Cancer Treatment

This investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative advanced breast cancer, with particular focus on developing therapeutic strategies for patients who have experienced disease progression after initial treatment.

  • Metastatic Breast Cancer Management
  • Endocrine Therapy Resistance
  • Combination Treatment Approaches

Their work encompasses innovative therapeutic combinations incorporating targeted agents with established treatments like fulvestrant.

HER2-Positive Breast Cancer

The investigator conducts research in advanced and metastatic HER2-positive breast cancer, focusing on novel therapeutic combinations with established targeted therapies like ado-trastuzumab emtansine (T-DM1).

  • Targeted Therapy Development
  • Treatment of Unresectable Disease
  • Novel Drug Combinations

Their expertise includes evaluating treatment responses in advanced breast cancer using standardized assessment criteria.

Long-term Endocrine Therapy

The investigator focuses on optimizing extended endocrine treatment strategies for breast cancer, particularly in high-risk luminal breast cancer patients who have completed initial therapy.

  • Extended Adjuvant Therapy
  • Treatment Switching Strategies
  • Post-menopausal Breast Cancer

Their research includes comparative studies of aromatase inhibitors and tamoxifen in various treatment sequences.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.